ClinicalTrials.gov
ClinicalTrials.gov Menu

The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00987012
Recruitment Status : Unknown
Verified September 2009 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : September 30, 2009
Last Update Posted : September 30, 2009
Sponsor:
Collaborator:
Gan-Shmuel Foods, Ltd.
Information provided by:
Hillel Yaffe Medical Center

Brief Summary:
It has been shown in laboratory studies that pomegranate juice contains anti-viral action against influenza. The researchers wish to investigate the effect of pomegranate juice on patients suffering from influenza A (seasonal or swine flu).

Condition or disease Intervention/treatment Phase
Influenza A Swine Flu Dietary Supplement: Pomegranate juice Dietary Supplement: Placebo drink Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients - A Prospective Randomized Trial
Study Start Date : October 2009
Estimated Primary Completion Date : April 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Flu Flu Shot

Arm Intervention/treatment
Experimental: Pomegranate juice Dietary Supplement: Pomegranate juice
Twice daily ingestion of pomegranate juice over 4-5 days

Placebo Comparator: Placebo drink Dietary Supplement: Placebo drink
Twice daily ingestion of placebo drink over 4-5 days




Primary Outcome Measures :
  1. Early relief of influenza symptoms [ Time Frame: Within one week ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Individuals confirmed and suffering from Influenza A

Exclusion Criteria:

  • Individuals suffering from influenza included in the high risk group

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00987012


Locations
Israel
Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Contact: Gershon Keren, MD    972-4-6304218    gershonk@hy.health.gov.il   
Contact: Izhak Braverman, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center
Gan-Shmuel Foods, Ltd.

Responsible Party: Dr. Gershon Keren, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT00987012     History of Changes
Other Study ID Numbers: 0044-09-HYMC
First Posted: September 30, 2009    Key Record Dates
Last Update Posted: September 30, 2009
Last Verified: September 2009

Additional relevant MeSH terms:
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases